Glassman Wealth Services’s BioNTech BNTX Stock Holding History

Glassman Wealth Services’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1684
2022 Q1	$0	Buy	+1	New	+$168	﹤0.01%	1657

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Glassman Wealth Services's BNTX Position: Q2 2022 in Review

Glassman Wealth Services sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 1 share.

Glassman Wealth Services first reported a position in BNTX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

Glassman Wealth Services reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
Glassman Wealth Services sold 1 BioNTech share in Q2 2022.
Glassman Wealth Services first reported a position in BioNTech in Q1 2022 and held it in 1 quarter.
Glassman Wealth Services's BioNTech position peaked at $0 in Q1 2022.
293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.